CASP3 and Cognitive impairment: The study demonstrated that treatment of the necroptosis-specific inhibitor necrostatin-1 to TBI mice significantly reduced brain tissue injury volume and improved cognitive function, without decreasing apoptosis-related caspase-3 activity, thereby highlighting the specific contribution of necroptosis to post-TBI cognitive impairment [55].